1. Introduction {#sec0005}
===============

Dairy sheep farming represents an important sector of livestock production in the Mediterranean basin, including Greece, with semi-intensive systems being the predominant ones. In these systems, feeding regimes are generally characterized by a combination of grazing on natural pasturelands and supplementary feeding of concentrates and roughages all year round ([@bib0245]). Also, under semi-intensive systems, sheep are often heavily challenged by parasitic infections during grazing, which represent one of the most important causes of poor health and welfare and reduced productivity at flock level. In particular, parasitic infections may be associated with reduced milk and meat production, lamb growth and ewe fertility, increased culling and replacement rate and predisposition to other diseases, which explains the reason why they are considered a major issue for the sustainability of the farms ([@bib0160], [@bib0135], [@bib0080], [@bib0060], [@bib0150], [@bib0090]).

*Teladorsagia*, *Haemonchus*, *Trichostrongylus*, *Nematodirus* and *Chabertia* are the commonest nematode genera of the wide spectrum of gastrointestinal nematodes (GIN) infecting sheep, throughout Europe ([@bib0175] ; [@bib0015]; [@bib0050]; [@bib0090]) and particularly among Mediterranean European countries, e.g. Spain ([@bib0225]), Italy ([@bib0040], [@bib0220]) and Greece ([@bib0160], [@bib0070]).

Routine anthelmintic treatments for the control of the fore mentioned parasites is the norm in sheep flocks, whereas, pasture management strategies are less commonly exploited ([@bib0205], [@bib0075], [@bib0120]). Although, evidence-based and targeted anthelmintic treatment remains the most effective strategy for the control of nematode infections ([@bib0200], [@bib0150]), the use of the commercially available anthelmintic drugs undergoes certain limitations, with the extended withdrawal periods during lactation and the development of resistance being the most significant ones ([@bib0090]).

Macrocyclic lactones are among the most popular antiparasitic drugs. Eprinomectin is a modern macrocyclic lactone with a high efficacy against GIN, lungworms and some ectoparasites in cattle ([@bib0040]). A few years ago, to overcome the shortfall of anthelmintic drugs with zero withdrawal period in milk, the off-label use of eprinomectin was adopted by some dairy sheep farmers and it was not until recently that eprinomectin was registered for use in dairy sheep. Today, it represents a promising anthelmintic drug with easy and welfare-friendly administration (pour-on) and zero withdrawal period in milk in sheep ([@bib0105]).

The anthelmintic efficacy of pour-on eprinomectin has been studied in sheep ([@bib0090], [@bib0095]), goats ([@bib0165]) and cattle ([@bib0170]). However, there is no research establishing the association between treatment of nematode-infected dairy sheep with eprinomectin and their milk yield or somatic cell counts (SCC) in milk. Therefore, the objective of the study was to evaluate the anthelmintic efficacy of eprinomectin and quantify its relationship with milk yield and SCC in milk of naturally infected dairy sheep flocks.

2. Materials and methods {#sec0010}
========================

2.1. Flocks history {#sec0015}
-------------------

Twelve flocks from three different regions (four farms per region) of the mainland Greece (Central Macedonia, Thessaly and Thrace) were included in the study. The average flock size was *ca.* 300 ewes with an average milk yield of about 290 L per ewe per lactation (250 days). The selected farms were representative of the typical semi-intensive dairy sheep farms in Greece, as described by [@bib0075]. Their feeding regime was similar and included grazing on natural pastures for 6--8 h per day throughout the study and supplementary feeding with concentrates and alfalfa hay (up to 1.0 kg for each divided in 2 meals) and *ad libitum* access to wheat straw and water. All ewes were milked twice per day and were at the middle of lactation (5 months post-lambing).

All the flocks of the study were following similar vaccination and antiparasitic programs. Namely, the ewes were vaccinated against *Clostridium* spp. and *Pasteurella* spp. (Dialuene P^®^, MSD) 20 days before parturition and six months later. Another vaccination against *Mycoplasma agalactiae* (Agalax^®^, SYVA) was performed 30 days before parturition and repeated 6 months later. The antiparasitic program included the oral administration of albendazole (10 mg/kg BW), 30 days before lambing. Ewes involved in the experiment had not received any anthelmintic treatment in the past 4 months prior to the beginning of the study.

2.2. Experimental design {#sec0020}
------------------------

The study was conducted between April and August 2015. Three hundred and sixty clinically healthy adult (2nd--4th lactation) dairy ewes (26--36 ewes per farm) in good body condition score (between 2.5 and 3.5 in the five-grade scale proposed by [@bib0195]) were randomly selected and included in the study. All ewes were milked twice per day and were at the middle of lactation (5 months post-lambing).

On each farm, the selected ewes (from a pool of ewes expelling more than 300 epg) were randomly divided into three similar groups (Group 1, 2 and 3). Group 1 consisted of 10 to 15 untreated ewes (control group), Group 2 consisted of 10 to 13 ewes treated with a single dose of eprinomectin at Day 0 and Group 3 consisted of 6 ewes repeatedly treated with eprinomectin at Days 0, 42 and 70. The commercial product used for the study was Eprinex^®^ pour-on (Merial) which was applied directly onto the skin along the backline in a strip extending from the withers to the tail head, at the dose rate of 1.0 mg/kg BW per treatment.

2.3. Faecal sampling and parasitological procedures {#sec0025}
---------------------------------------------------

Faecal samples were collected from each individual ewe of the three groups on Days 0, 7, 14, 28, 42, 56, 70, 84 and 98. These samples were collected directly from the rectum of the ewes, using single-use plastic gloves and lubricant. The samples were then stored and transferred to the laboratory in isothermal containers (2 to 4 °C). Sampling was done by a trained veterinarian and according to animal welfare principles and regulations to avoid any unnecessary distress for the animals.

Individual faecal egg counts (FEC) for nematode parasite eggs were assessed using a quantitative modified McMaster technique with a sensitivity of 50 eggs per g of faeces (EPG) ([@bib0155]).

Moreover, pooled faecal samples, from each farm, on the fore mentioned sampling occasions, were processed for coprocultures ([@bib0155]). The nematode larvae were recovered using the Baermann technique, after an incubation period of 7--10 days ([@bib0190]). Morphological identification of 100 (when possible) parasitic nematode L~3~ larvae was performed according to morphological keys of [@bib0230].

2.4. Milk sampling for the measurement of the Somatic Cell Counts {#sec0030}
-----------------------------------------------------------------

In every sampling occasion, individual milk samples were collected in the milking parlor from a subset of five selected ewes (the same every time) per group for each farm. Following proper disinfection of the udder with isopropyl alcohol and the withdrawal of the initial 2--3 squirts of milk, a milk sample (*ca*. 50 mL), was collected in plastic tube with lid, taking approximately equal volumes from each udder half. The measurement of SCC was performed using an automatic high-throughput analyzer Fossomatic^™^ FC (Foss).

2.5. Milk yield {#sec0035}
---------------

During the sampling occasions, ewes were hand-milked and the volume of the produced milk per ewe per milking was recorded using a graduated measuring cylinder (Ilmenau Company). Daily milk yield (DMY) was estimated using one of the two milkings (morning or evening) and making the adjustments according to ICAR recommendations (AT4 method).

2.6. Statistical analysis {#sec0040}
-------------------------

Data were analyzed using SPSS 23. Descriptives were calculated and followed by analytical statistics. Univariate analysis of variance was used to compare the average values of FEC, DMY and SCC between the three groups for each sampling occasion separately, after adjusting for the farm's effect. The results were used to draw FEC, DMY and SCC curves for each of the three groups during the study. Three mixed linear regression models were built to quantify the effects of treatment with eprinomectin and the days post-treatment on FEC, DMY and SCC, for the g^th^ sampling occasion, of the hth ewe in the ith flock (EPG~ghi~) as described below:where: μ = intercept, E~ghi~ = fixed effect of treatment group (3 levels, 0 = no treatment, 1 = treatment with Eprinomectin at day 0, 2 = three treatments with Eprinomectin at days 0, 42 and 70), D~hi~ = fixed effect of sampling time (10 levels, 1st, 2nd,..... 10th sampling occasion), *γ*~hi~= repeated variation of the hth ewe in the ith flock, *δ*~i~ = random variation in the ith herd and e~ghi~ = residual error. First order autoregressive was used as covariance structure in the models.

For the models estimating the effects on DMY and SCC, the fixed effect of the regression coefficient of the parasitic load expressed in EPG was also calculated. In these models the levels of sampling time were 9. The assumptions of homoscedasticity, normal distribution and linearity for the models were checked by visually assessing the plots of standardized residuals against standardized predicted values and histograms, as well as the probability-probability and quantile-quantile plots of standardized residuals.

Species richness and species diversity of nematodes were calculated using the Menhinick's (D) and Shannon (H) index, respectively, as described below:$$D = \frac{S}{\sqrt{N}}$$$$H = {\sum\limits_{i = 1}^{S}\left. p_{i}\, \middle| {\text{ln}{p_{i}\text{| }}} \right.}$$where S equals the number of different nematode species, N equals the total number of the sampled ewes and p~i~ represents the proportion of the total number of the parasites that are in species "i". D-index was measured to demonstrate the number of different species of nematodes found in the studied sheep population. H-index was complementary used as a more reliable index of biodiversity accounting both for the numbers of species of nematodes and the dominance or evenness of species in relation to one another.

The overall efficacy of treatment with eprinomectin at each group was calculated as follows:$$\left( \text{\%} \right)\text{ efficacy=100×}\frac{\text{C-T}}{\text{C}}$$where C represents the arithmetic mean FEC for control ewes (Group 1) and T the arithmetic mean FEC for treated ewes (Group 2 and 3). Statistical significance was set at a = 0.05 level.

3. Results {#sec0045}
==========

The topical application of eprinomectin (Eprinex^®^, Merial) was well tolerated and no local or general adverse reactions were observed, across the present study.

Overall, the most prevalent nematode parasites found in all studied regions at Day 0 were *Teladorsagia* spp. (67%), followed by *Haemonchus* spp. (28%) and *Trichostrongylus* spp. (2%). Furthermore, *Haemonchus* spp. presented a higher infection rate in ewes from Thessaly than in those of Macedonia and Thrace ([Table 1](#tbl0005){ref-type="table"}).Table 1Number and proportion (%) of L~3~ larvae (per parasite taxon), mean species richness (Menhinick's index) and species diversity (Shannon index) per group, in the three studied regions, at Days 0, 14 and 98.Table 1Region (no. of examined ewes)TelHaeTriChabBunDHDay 0Group 1Macedonia (n = 47)309 (78.2)75 (18.9)9 (2.3)1 (0.3)1 (0.3)0.730.63Thessaly (n = 44)216 (55.7)157 (40.4)10 (2.6)3 (0.8)2 (0.5)0.750.85Thrace (n = 49)290 (73.1)95 (24.0)9 (2.3)1 (0.3)1 (0.3)0.710.69  Group 2Macedonia (n = 42)308 (78.4)80 (20.4)4 (1.0)0 (0.0)1 (0.2)0.610.57Thessaly (n = 44)208 (53.3)165 (42.3)12 (3.1)2 (0.5)3 (0.8)0.750.87Thrace (n = 45)289 (73.2)103 (26.1)2 (0.5)0 (0.0)1 (0.2)0.590.62  Group 3Macedonia (n = 24)298 (75.6)85 (21.6)7 (1.8)2 (0.5)2 (0.5)1.020.67Thessaly (n = 23)205 (54.9)153 (41.0)13 (3.5)1 (0.3)1 (0.3)1.040.85Thrace (n = 24)281 (71.1)102 (25.8)8 (2.1)2 (0.5)2 (0.5)1.020.73  Day 14Group 1Macedonia (n = 45)306 (78.9)73 (18.8)7 (1.7)1 (0.3)1 (0.3)0.750.61Thessaly (n = 41)208 (53.3)162 (41.5)19 (4.9)1 (0.3)0 (0.0)0.630.87Thrace (n = 49)293 (74.6)91 (23.1)8 (2.0)0 (0.0)1 (0.3)0.570.65  Group 2Macedonia (n = 42)58 (55.7)40 (38.5)4 (3.8)1 (1.0)1 (1.0)0.770.91Thessaly (n = 44)49 (59.0)31 (37.3)3 (3.7)0 (0.0)0 (0.0)0.450.8Thrace (n = 44)48 (57.1)30 (35.7)4 (4.8)1 (1.2)1 (1.2)0.750.94  Group 3Macedonia (n = 24)25 (64.1)13 (33.3)1 (2.6)0 (0.0)0 (0.0)0.610.75Thessaly (n = 22)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)00Thrace (n = 23)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)00  Day 98Group 1Macedonia (n = 44)297 (75.5)90 (22.9)5 (1.3)0 (0.0)1 (0.3)0.60.62Thessaly (n = 39)206 (52.2)179 (45.3)7 (1.7)2 (0.5)1 (0.3)0.80.81Thrace (n = 49)280 (71.4)101 (25.7)8 (2.0)1 (0.3)2 (0.6)0.710.72  Group 2Macedonia (n = 40)93 (60.0)56 (36.1)6 (3.9)0 (0.0)0 (0.0)0.470.8Thessaly (n = 44)163 (53.6)125 (41.1)15 (4.9)0 (0.0)1 (0.4)0.60.87Thrace (n = 44)166 (66.4)75 (30.0)7 (2.8)0 (0.0)2 (0.8)0.60.77  Group 3Macedonia (n = 24)42 (59.1)27 (38.0)2 (2.9)0 (0.0)0 (0.0)0.610.78Thessaly (n = 23)132 (53.6)101 (41.1)10 (4.1)1 (0.4)2 (0.8)1.040.89Thrace (n = 24)148 (65.7)72 (32.1)4 (1.8)0 (0.0)1 (0.4)0.820.74[^1][^2]

The overall efficacy and the efficacy of eprinomectin treatment on the most pathogenic GIN genera i.e. *Teladorsagia* and *Heamonchus*, on Days 7, 14, 28, 42, 56, 70, 84 and 98 for Groups 2 and 3, are presented in [Table 2](#tbl0010){ref-type="table"}, [Table 3](#tbl0015){ref-type="table"}, respectively. In Group 2, the overall efficacy was higher than 95% at Days 7, 14 and 28, whereas, in Group 3 the overall efficacy was higher than 99% at least for the first 70 days after the first treatment ([Table 2](#tbl0010){ref-type="table"}). Moreover, the individual efficacies against *Teladorsagia* and *Haemonchus* spp. confirmed the above findings ([Table 3](#tbl0015){ref-type="table"}).Table 2Mean (±SD) faecal egg counts per group of ewes and the anthelmintic efficacy (%) of Eprinex^®^ across the study.Table 2Group 1Group 2Group 3DayFaecal egg countFaecal egg countEfficacyFaecal egg countEfficacy7821.87 (±253.02)11.06 (±6.52)98.70 (±0)100.014964.66 (±275.34)16.32 (±11.53)98.31.39 (±3.24)99.9281085.11 (±315.75)40.65 (±17.82)96.31.39 (±3.24)99.8421059.21 (±256.73)65.22 (±32.57)93.83.75 (±7.25)99.7561052.38 (±230.74)113.87 (±52.05)89.26.67 (±8.52)99.470935.25 (±148.32)148.11 (±62.61)84.21.39 (±3.24)99.984739.01 (±155.380)194.24 (±118.89)73.725.14 (±15.43)96.698485.57 (±56.17)194.30 (±69.87)60.018.21 (±14.79)96.2[^3]Table 3Mean calculated number of L~3~ larvae of the genera *Teladorsagia* and *Haemonchus* and the anthelmintic efficacy (%) of Eprinex^®^ per parasite genus per sampling occasion.Table 3Parasite generaGroup 1Group 2Group 3L~3~ larvaeL~3~ larvaeEfficacyL~3~ larvaeEfficacy**Day 7**Tel600.947.3098.790.00100.00Hae200.883.1198.450.00100.00**Day 14**Tel670.449.3098.610.8899.87Hae270.976.1197.750.4799.83**Day 28**Tel770.4429.3096.200.8899.89Hae288.4210.6496.310.4799.84**Day 42**Tel720.9940.3094.412.0199.72Hae320.9724.2192.461.6099.50**Day 56**Tel723.0471.6090.104.0099.45Hae316.4740.4287.232.2099.30**Day 70**Tel661.0383.6087.350.9899.85Hae250.9753.4278.710.3799.85**Day 84**Tel550.94107.6080.4715.0097.28Hae169.0273.4256.566.8495.95**Day 98**Tel322.22115.6564.1110.8296.64Hae152.2770.1653.926.7295.59[^4][^5]

[Table 1](#tbl0005){ref-type="table"} summarizes the number and proportion (%) of L~3~ larvae (per parasite taxon), mean species richness (Menhinick's index, D index) and species diversity (Shannon index, H index) per group, in the three studied regions, at Days 0, 14 and 98. Menhinick's index values observed in the studied regions varied from 0.59 to 1.04, 0.00 to 0.77, 0.47 to 1.04, whereas, Shannon index varied from 0.57 to 0.87, 0.00 to 0.94 and 0.62 to 0.89, for Days 0, 14 and 98, respectively ([Table 1](#tbl0005){ref-type="table"}). The highest D and H indexes were observed in Thessaly in all sampling occasions and studied groups, with the exception of Day 14 ([Table 1](#tbl0005){ref-type="table"}).

As presented in [Table 4](#tbl0020){ref-type="table"}, untreated ewes had significantly higher parasitic load when compared with ewes treated by eprinomectin once or thrice (increased by 522 and 606 EPG, respectively, P ≤ 0.001). The evolution of FEC (EPG) across the studied period for the three groups is presented in [Fig. 1](#fig0005){ref-type="fig"}. FEC of Group 1 (untreated group) were significantly higher (P ≤ 0.05) than those of Group 2 and 3, in every sampling occasion after Day 0. Furthermore, FEC in Group 2 were significantly higher (P ≤ 0.05) than in Group 3 from Day 42 to Day 98.Table 4Effects of eprinomectin treatment and sampling on the faecal egg counts (EPG) in the studied ewes population.Table 4ParameterCategory levelBSEP-valueLowerUpper95% CITreatmentNo treatment60625.40.000556656Eprinomectin at 0 d8425.60.00134135Eprinomectin at 0, 42 and 70 d"Ref"Sampling timeDay -1423221.70.000189274Day 032820.80.000288369Day 73520.50.091−675Day 149620.20.00056136Day 2815319.70.000114191Day 4215818.90.000121195Day 5617517.70.000140210Day 7013515.70.000105166Day 847912.10.00055103Day 98"Ref"InterceptContinuous2223.80.363−2568[^6]Fig. 1Mean curves, showing the effect of eprinomectin (Eprinex^®^, Merial) on faecal egg count (EPG) among three different groups of ewes per sampling occasion.a, b, c different superscripts indicate statistical differences (P\<0.05) of faecal egg count among three groups of ewes per sampling.Group 1: No eprinomectin treatment (control group), Group 2: Eprinomectin treatment at day 0, Group 3: Eprinomectin treatment at days 0, 42 and 70.Fig. 1

As presented in [Table 5](#tbl0025){ref-type="table"}, in Groups 2 and 3, DMY was increased by *ca.* 5% (50 mL/day) and 11% (105 mL/day), respectively (P \< 0.001), compared to Group 1 (untreated ewes [Table 5](#tbl0025){ref-type="table"}). [Fig. 2](#fig0010){ref-type="fig"} demonstrates the milk yield curves of the three studied groups during the study period. Milk yield of the untreated ewes (Group 1) was significantly lower (P ≤ 0.05) when compared with milk yield of Groups 2 and 3, in every sampling occasion after Day 0. Furthermore, Group 3 produced significant (P ≤ 0.05) higher amount of milk than those of Group 2, on Days 28 and 42.Table 5Effects of eprinomectin treatment and sampling on the milk yield (L) in the studied ewes population.Table 5ParameterCategory levelBSEP-valueLowerUpper95% CITreatmentNo treatment0.1050.0200.000−0,144-0.144−0.066Eprinomectin at 0 d0.0540.0160.001−0,085-0.085−0.024Eprinomectin at 0, 42 and 70 d"Ref"Sampling timeDay 00.2310.0180.0000.1950.268Day 70.4210.0170.0000.3870.456Day 140.5780.0170.0000.5440.612Day 280.7290.0170.0000.6950,764Day 420.7520.0170.0000.7180.785Day 560.6910.0170.0000.6580.724Day 700.5300.0160.0000.5000.561Day 840.2740.0130.0000.2480.299Day 98"Ref"InterceptContinuous0.6360.0160.0000.6050.667[^7]Fig. 2Mean curves showing the effect of eprinomectin (Eprinex^®^, Merial) on milk yield (L) among three different groups of ewes per sampling occasion.a, b, c different superscripts indicate statistical differences (P\<0.05) of milk yield among three groups of ewes per sampling.Group 1: No eprinomectin treatment (control group), Group 2: Eprinomectin treatment at day 0, Group 3: Eprinomectin treatment at days 0, 42 and 70.Fig. 2

Finally, as presented in [Table 6](#tbl0030){ref-type="table"}, in Group 2 and 3 SCC were reduced by *ca.* 14% (165\*10^3^ cells/mL) and 20% (229\*10^3^ cells/ml), respectively, compared to those of Group 1. [Fig. 3](#fig0015){ref-type="fig"} presents the SCC curves of the three studied groups during the study period. SCC of the untreated ewes (Group 1) was significantly higher (P ≤ 0.05) when compared with SCC of Groups 2 and 3, in every sampling occasion after Day 0.Table 6Effects of eprinomectin treatment and sampling on the somatic cell counts (\*10^3^ cells/ml) in the studied ewes population.Table 6ParameterCategory levelBSEP-valueLowerUpper95% CITreatmentNo treatment229.38638.4830.000153.361305.411Eprinomectin at 0 d64.55137.6750.089−9.985139.088Eprinomectin at 0, 42 and 70 d"Ref"Sampling timeDay 032.96924.3690.177−14.87580.812Day 729.96522.7660.189−14.72974.658Day 1414.63621.9300.505−28.41057.681Day 284.16420.9020.842−36.85945.188Day 4218.12319.4560.352−20.06156.308Day 5611.50417.6040.514−23.04546.053Day 709.65015.0390.521−19.86739.167Day 8418.98111.1800.090−2.96340.926Day 98"Ref"InterceptContinuous891.43331.6010.000829.037953.828[^8]Fig. 3Mean curves, showing the effect of eprinomectin (Eprinex^®^, Merial) on somatic cell counts (\*10^3^ cells/ml) among three different groups of ewes per sampling occasion.a, b, c different superscripts indicate statistical differences (P\<0.05) of somatic cell counts among three groups of ewes per sampling.Group 1: No eprinomectin treatment (control group), Group 2: Eprinomectin treatment at day 0, Group 3: Eprinomectin treatment at days 0, 42 and 70.Fig. 3

4. Discussion {#sec0050}
=============

This field trial assessed the beneficial effect of eprinomectin pour-on administration (once or thrice) on daily milk yield (DMY) and somatic cell counts (SCC) in twelve semi-intensive dairy sheep flocks, naturally infected with GIN.

The beneficial effect of the treatment with antiparasitic drugs (other than eprinomectin), such as albendazole, netobimin, moxidectin, on the DMY of dairy ewes has been previously confirmed in several studies ([@bib0115], [@bib0100], [@bib0065]). For example, [@bib0115] recorded an increase of the DMY from ewes treated twice (4 weeks apart) with netobimin after lambing. In another study, the use of albendazole (3.8 mg/kg BW) and moxidectin (0.2 mg/kg BW) increased significantly the volume of the produced milk in dairy ewes of Lacaune breed post-weaning, under Greek conditions ([@bib0065]). However, the above anthelmintic treatments are accompanied by limitations regarding their use during the lactation period due to the milk withdrawal period.

Eprinomectin is a macrocyclic lactone to be used as a topical formulation with high efficacy against nematodes of gastrointestinal track, respiratory system and some ectoparasites ([@bib0040]). This formulation is characterized by a broad safety margin and zero milk withdrawal period compared to other anthelmintic drugs (e.g. albendazole) due to a low milk partitioning coefficient, which is an unique pharmacokinetic property of the macrocyclic lactones class ([@bib0090]). Even though, many surveys have confirmed its beneficial effect on DMY of grazing dairy cows, there is still lack of research regarding dairy ewes. [@bib0240] reported that grazing dairy cows increased their DMY approximately 1.15, 1.46 and 5.52 L on days 20, 50 and 86 post-partum, respectively, after a single administration of pour-on eprinomectin, at the recommended dose rate, compared with the untreated control cows. At the same time, [@bib0185] recorded a 2.14 L increase of daily milk production per cow within the first month post eprinomectin administration, when grazing period was over and the cows remained permanently housed. Similarly, [@bib0180] confirmed the beneficial effect of topically administered eprinomectin on milk production of the cows due to reduction of nematode infection intensity, which has also been found to be the case in grazing dairy cows, treated during lactation or at calving ([@bib0085], [@bib0020]). In contrast, there is one study in which no significant effect of eprinomectin treatment on milk production was observed; however, in the latter study the herds had no or limited grazing exposure ([@bib0210]).

Our results provide novel data to support the increase of DMY due to an anthelmintic administration, in particular the pour-on eprinomectin, in dairy ewes naturally infected by nematodes. An increase of 105 mL/day and 50 mL/day in DMY was observed for ewes treated thrice (Group 3) and once (Group 2), respectively, comparing to the control group (average DMY was *ca.* 970 mL). Hence, the total increase in milk yield was *ca.* 10.3 L and 4.9 L for ewes in Group 3 and 2, respectively, considering that the duration of the present study was 98 days. Previous studies conducted in dairy small ruminants have shown that GIN act by reducing the availability of nutrients that are likely to be partitioned for milk production ([@bib0115], [@bib0100], [@bib0235]). Therefore, a possible explanation for the increase of milk production in our study is that a greater nutrient supply that was afforded by the treated ewes during the persistent period post eprinomectin administration was sufficient to enhance the milk production ([@bib0045]). It is obvious that further elucidation of these mechanisms should be done in order to maximize the benefit from the use of these anthelmintic protocols.

The increased milk yield resulted in about 9.27€ and 4.41€ extra profit per ewe for groups 3 and 2, respectively (0.90 €/L was the average milk price in Greece during the study). The cost per single administration of eprinomectin was estimated at 2.04 €/ewe (for a ewe weighing 60 kg, at a dose rate of 1 mg/kg BW). According to the calculations the total benefit for ewes treated thrice and ewes treated once was 3.25€ and 2.37€, whereas for the average sheep flock in the study (n = 300 ewes), the total benefit for the 98 days of the study could be 975€ and 711€, respectively. In any case, this is a rough estimation of the short term (mid to end of milking period) economic benefits from using eprinomectin. Longitudinal studies need to be undertaken to assess the direct and indirect benefits of eprinomectin (e.g. improvement of milk quality and ewes' health and welfare status, better feed efficiency, reduced replacement rate, etc.) on farm's economics and sustainability.

The reduction of the SCC in milk samples after the administration of the pour-on eprinomectin is a novel finding for dairy ewes, indicating an improvement of udder health status and milk quality post treatment. The beneficial effect of eprinomectin treatment on SCC has been studied in grazing cattle. For example, [@bib0180] reported a reduction in SCC of grazing cows on the second day after the administration of pour-on eprinomectin on these animals. In agreement with the previous results, [@bib0240] recorded a reduction in SCC in eprinomectin treated cows, when compared with untreated ones, on Days 20 and 50 post calving. It is well known that GIN parasitism and especially *Teladorsagia* spp. can lead to protein and therefore, immunoglobulin deficiency ([@bib0215]). GIN parasitism suppresses the defense mechanisms of the mammary gland of the ewe predisposing to increase of SCC and appearance of clinical ([@bib0145]) or subclinical mastitis ([@bib0125]). According to [@bib0030], reduced energy availability has been recorded during trichostrongylosis (i.e. parasites engage energy sources) which can lead to decreased neutrophil function (i.e. delayed mobilization to the mammary gland, impaired phagocytosis, inefficient intracellular killing) contributing to mastitis ([@bib0145]). In our study, eprinomectin administration reduced GIN burden in dairy ewes and lead to reduced SCC in milk by suppressing the forementioned mechanisms.

Based on the results of coprocultures, third stage larvae of *Teladorsagia*, *Haemonchus* and *Trichostrongylus* were most prevalent in the studied sheep population. It was evident that *Teladorsagia* remained the most commonly found nematode genus, even though an increase of *Haemonchus* infection has been recorded. These findings are in accordance with the results reported previously in large scale studies conducted in dairy sheep and goats in central and northern Greece ([@bib0160], [@bib0070]).

A significant increase of FEC of untreated ewes (Group 1) was observed in our study. This sharp increase was more than double at the end of April (i.e. within a month from the start of the trial). The seasonal pattern for the increase of GIN parasite burdens in naturally infected ewes has been previously reported by [@bib0160], who found that the nematode infection intensity started to increase significantly from February and peaked during spring. A possible explanation for this sharp increase is that the moisture-temperature levels favor parasite survival rates, which in combination with increased grazing time during spring, enhance the risk of infection ([@bib0160], [@bib0110]).

Efficacy studies, conducted in sheep ([@bib0090], [@bib0095]), goats ([@bib0165]) and cattle ([@bib0170]), reported high anthelmintic efficacy of pour-on formulation of eprinomectin, at the recommended dosage, for each of the forementioned animal species. In our study, the efficacy of topically administered eprinomectin was also high (\>90%) for the first 42 days post treatment. This beneficial effect was further extended for 60 days (i.e. from Day 42 to 98, in ewes treated thrice). In our study, a long term effect of eprinomectin was evidenced. This has also been reported by other studies assessing the effectiveness of pour-on eprinomectin against experimental or natural GIN infection of goats ([@bib0025]) and cattle ([@bib0035]) for a period over 28 days post treatment.

However, factors such as the fleece length ([@bib0040]), as well as the licking behavior ([@bib0130], [@bib0010]), have been identified to interact with drug delivery and therefore, potentially with drug efficacy. For this reason, pour-on eprinomectin is recommended to be administered directly onto the skin from the withers to the start of tail after parting or shearing the fleece. It is important to note that the eprinomectin excipient limits the environmental accumulation of the drug, by reducing unabsorbed quantities to be rinsed off the fleece during a rainfall ([@bib0140]). In cattle, rainfall, according to the SPC of the product, does not affect the absorbance of the drug when administered topically, but in sheep there is no relative data available ([@bib0055]). In order to overcome the possible limitations from pour-on administration in sheep, the oral administration of eprinomectin has been investigated and found to be highly effective as well ([@bib0005]). However, to the best of our knowledge, meat and milk residual analyses after the oral administration of eprinomectin in sheep are scarce.

5. Conclusion {#sec0055}
=============

This study confirmed the high efficacy of eprinomectin against the GIN of sheep. Ewes treated once or thrice had significantly lower FEC than the untreated ones. Furthermore, ewes treated thrice had lower FEC, than the ones treated once, from day 42 to day 98 (end of the study). It is reported for the first time the beneficial effect of pour-on eprinomectin on the daily milk yield of dairy ewes. Ewes treated once or thrice presented an increase of daily milk yield by *ca.* 5% (50 mL/day) and 11% (105 mL/day), respectively, compared to untreated ewes. Finally, the reduction of the somatic cell counts was an additional supporting result towards the improvement of udder health status and milk quality post eprinomectin treatment of dairy ewes.
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[^1]: Tel: *Teladorsagia* spp., Hae: *Haemonchus* spp., Tri: *Trichostrongylus* spp., Chab: *Chabertia* spp., Bun: *Bunostomum* spp. D: Menhinick's species richness index, H: Shannon species diversity index.

[^2]: Group 1: No eprinomectin treatment (control group), Group 2: Eprinomectin treatment at day 0, Group 3: Eprinomectin treatment at days 0, 42 and 70.

[^3]: Group 1: No eprinomectin treatment (control group), Group 2: Eprinomectin treatment at day 0, Group 3: Eprinomectin treatment at days 0, 42 and 70.

[^4]: Tel: *Teladorsagia* spp., Hae: *Haemonchus* spp.

[^5]: Group 1: No eprinomectin treatment (control group), Group 2: Eprinomectin treatment at day 0, Group 3: Eprinomectin treatment at days 0, 42 and 70.

[^6]: CI: Confidence interval; B: Coefficient; SE: Standard error; "Ref": Reference category.

[^7]: CI: Confidence interval; B: Coefficient; SE: Standard error; "Ref": Reference category.

[^8]: CI: Confidence interval; B: Coefficient; SE: Standard error; "Ref": Reference category.
